RVL Pharmaceuticals Plc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RVLPQ and buy or sell other stocks, ETFs, and their options commission-free!About RVLPQ
RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, Lorzone, and M-72.
CEOBrian A. Markison, CPA
CEOBrian A. Markison, CPA
Employees125
Employees125
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded1986
Founded1986
Employees125
Employees125
RVLPQ Key Statistics
Market cap11.14K
Market cap11.14K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume234.80
Average volume234.80
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0001
52 Week high$0.0001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
With a market cap of 11.14K, RVL Pharmaceuticals Plc(RVLPQ) trades at $0.00.
On 2026-09-07, RVL Pharmaceuticals Plc(RVLPQ) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for RVL Pharmaceuticals Plc(RVLPQ) stock has reached 0, versus its average volume of 234.8.
The stock's 52-week range extends from a low of $0.00 to a high of $0.00.
The stock's 52-week range extends from a low of $0.00 to a high of $0.00.
People also own
Based on the portfolios of people who own RVLPQ. This list is generated using Robinhood data, and it’s not a recommendation.